Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMYDA-CARO: Clopidogrel and Atorvastatin in Carotid Stenting
NCT01572623Phase 4Unknown
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jul 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel and atorvastatin in carotid artery stenosis (4 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Incidence of cerebral damage (TIA/stroke or new ischemic lesions on DWI-MRI) at 30 days. Status: unknown.
02
Drugs
clopidogrelatorvastatin
03
Conditions
carotid artery stenosis
Beyond the preview
Go deeper on NCT01572623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01572623.